Cargando…
Graves’ Disease after mRNA COVID-19 Vaccination, with the Presence of Autoimmune Antibodies Even One Year Later
A 45-year-old man who had received his second mRNA COVID-19 vaccination one week earlier was presented to the emergency department with chest discomfort. Therefore, we suspected post-vaccination myocarditis; however, the patient showed no signs of myocarditis. After 2 weeks, he revisited the hospita...
Autores principales: | Nakamura, Fuminori, Awaya, Toru, Ohira, Masahiro, Enomoto, Yoshinari, Moroi, Masao, Nakamura, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222727/ https://www.ncbi.nlm.nih.gov/pubmed/37243038 http://dx.doi.org/10.3390/vaccines11050934 |
Ejemplares similares
-
A Possibility of Vasospastic Angina after mRNA COVID-19 Vaccination
por: Awaya, Toru, et al.
Publicado: (2022) -
What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions
por: Awaya, Toru, et al.
Publicado: (2022) -
Effect of Membranous Septal Length on the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation
por: Kozai, Yuki, et al.
Publicado: (2021) -
Impact of right atrial structural remodeling on recurrence after ablation for atrial fibrillation
por: Takagi, Takahito, et al.
Publicado: (2021) -
Paget-Schroetter Syndrome Resulting from Thoracic Outlet Syndrome and KAATSU Training
por: Noto, Tatsunori, et al.
Publicado: (2017)